Author: Ravi Shankar

CHICAGO, Oct. 21, 2026 (GLOBE NEWSWIRE) — XAI Floating Rate & Alternative Income Trust (NYSE: XFLT) (the “Fund”), announced today the final results of its Tender Offer (the “Tender Offer”), which commenced September 18, 2026, and expired at 11:59 p.m., Eastern Time, on October 19, 2026. The Tender Offer was for up to 1,903,861 (approximately 12.5%) of the Fund’s outstanding common shares of beneficial interest, par value $0.01 per share (“Common Shares”). The purchase price of validly tendered and accepted Common Shares for the Fund will be 98% of the Fund’s net asset value (“NAV”) as of the close of regular trading on the New York Stock Exchange on October 20, 2026.

The table below shows the final results of the Tender Offer as calculated by Computershare Trust Company, N.A. the depositary for the Tender Offer (the “Depositary”):

Tender Offer Amount	Shares Validly Tendered	Shares to be Purchased	Pro-Ration Factor*		Purchase Price of Validly Tendered Shares**		Number of Outstanding Common Shares after Giving Effect to Tender Offer
Up to 12.5% or 1,903,861 Shares	7,331,021	1,903,861	26.01%		$21.0602		13,327,023

* The number of Common Shares to be purchased divided by the number of Common Shares validly tendered. The pro-ration factor is subject to rounding adjustment to avoid the purchase of fractional shares.

** The purchase price of validly tendered and accepted Common Shares will be 98% of the Fund’s net asset value (“NAV”) as of the close of regular trading on the New York Stock Exchange on October 20, 2026.

Questions regarding the Tender Offer may be directed to Okapi Partners LLC, the Information Agent for the Tender Offer, who can be reached at the toll-free number (877) 796-5274.

About XA Investments

XA Investments LLC (“XAI”) is a Chicago-based firm founded by XMS Capital Partners in 2016. XAI serves as the investment adviser for two listed closed-end funds, an interval fund, and a tender offer fund. The listed closed-end funds, the XAI Floating Rate & Alternative Income Trust and XAI Madison Equity Premium Income Fund both trade on the New York Stock Exchange and the interval fund and tender offer fund, XAI CLO & Income Opportunities Fund and Evanston Multi-Alpha Fund are both available via direct subscription and through select broker/dealers and wealth management platforms.

In addition to investment advisory services, the firm also provides investment fund structuring and consulting services focused on registered closed-end funds to meet institutional client needs. XAI offers custom product build and consulting services, including product development and market research, marketing and fund management.

XAI believes that the investing public can benefit from new vehicles to access a broad range of alternative investment strategies and managers. XAI provides individual investors with access to institutional-caliber alternative managers. For more information, please visit www.xainvestments.com.

About XMS Capital Partners

XMS Capital Partners, LLC, established in 2006, is a global, independent, financial services firm providing M&A, corporate advisory and asset management services to clients. It has offices in Chicago, Boston and London. For more information, please visit www.xmscapital.com.

About Rockford Tower Asset Management

Rockford Tower Asset Management, L.L.C. is a wholly owned subsidiary of King Street Capital Management, L.P. (“King Street”) and an affiliate of Rockford Tower Capital Management (“Rockford Tower”). Rockford Tower, King Street’s dedicated CLO, CBO and SMA platform, was formed in 2017. Rockford Tower has over $14.7 billion of assets under management as of September 30, 2026, across 19 U.S. CLOs and 10 European CLOs, one CBO transaction and one SMA. In addition, Rockford Tower has traded over $99 billion of loans as of December 31, 2025.

About King Street Capital Management

King Street is a global alternative investment firm founded in 1995 that manages $30.9 billion in assets across public and private markets. The firm marries rigorous fundamental research with tactical trading and differentiated sourcing capabilities to identify investment opportunities across asset classes, up and down the capital structure. For more information, please visit www.kingstreet.com.

XAI does not provide tax advice; please consult a professional tax advisor regarding your specific tax situation. Income may be subject to state and local taxes, as well as the federal alternative minimum tax.

Investors should consider the investment objectives and policies, risk considerations, charges and expenses of the Fund carefully before investing. For more information on the Fund, please visit the Fund’s webpage at www.xainvestments.com.

This press release shall not constitute an offer to sell or a solicitation to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer or solicitation or sale would be unlawful prior to registration or qualification under the laws of such state or jurisdiction.

NOT FDIC INSURED		NO BANK GUARANTEE		MAY LOSE VALUE

Paralel Distributors, LLC – Distributor

Media Contact: 
Kimberly Flynn, President
XA Investments LLC
Phone: 888-903-3358
Email: KFlynn@XAInvestments.com
www.xainvestments.com

Subscription-based platform designed to help businesses compete for visibility on ChatGPT and Gemini, positioning Change Agents to capitalize on the shift toward AI-powered search

FREEHOLD, N.J., Oct. 21, 2026 (GLOBE NEWSWIRE) — Change Agents Corporation (Nasdaq: CHGA) (“Change Agents” or the “Company”), a technology company developing commercial agentic AI software through its wholly owned subsidiary, Avalon Quantum AI, LLC, and pursuing AI-enabled drone technologies through a separate wholly owned subsidiary, Autonomous Air Defense Systems LLC, today announced that it plans to commercially launch Beacon, a subscription-based Agentic Generative Search Optimization (GEO) platform designed to help small businesses improve their visibility across the five leading AI assistants; ChatGPT, Gemini, Perplexity, Grok and Claude.

The platform will go live on October 28, 2026, with additional information available at www.changeagentscorp.com/beacon/. Beacon is designed to help small businesses understand how they appear in AI-powered search results, identify opportunities to improve their online visibility, and attract potential customers.

Beacon has been developed to potentially address an emerging challenge for small businesses as consumers increasingly turn to AI assistants to discover local businesses, compare services, and make purchasing decisions, namely “Is AI recommending my business?”. Unlike traditional search engines, AI assistants can provide direct recommendations to consumers, creating a new competitive environment in which businesses need to understand whether they are being recommended and how they compare with competitors.

The platform deploys an AI agent to analyze a business’s online presence, customer reviews, reputation, and visibility across AI assistants. It then provides actionable recommendations designed to help business owners improve how their businesses are discovered and represented in AI-generated responses.

“AI is fundamentally changing how consumers discover businesses, yet most small business owners have little visibility into whether their companies are being recommended by AI assistants,” said Michael Mathews, Director of Change Agents Corp. “Beacon is designed to make this emerging technology accessible and affordable for small businesses. For just $20 per month, business owners can gain valuable insight into their AI visibility, understand how they compare with competitors, and identify practical steps to improve their online presence. We believe Beacon addresses a growing market need while establishing an opportunity for Change Agents to build a scalable, subscription-based software business.”

AI-Powered Visibility Audits and Subscription-Based Monitoring

Beacon is designed to provide small businesses with an accessible, straightforward process for understanding and improving their visibility across the leading AI assistants.

The platform’s principal features include:

• Free AI Visibility Audit: Following a simple registration and email verification process, Beacon’s AI agent conducts a free visibility audit in five minutes or less, evaluating the completeness of a business’s online profile, customer reviews and reputation, and how frequently AI assistants recommend the business relative to its major competitors.
• Competitive Visibility Analysis: The platform evaluates business recommendations across approximately 100 common customer queries, providing insight into how a business compares with competitors when potential customers use AI assistants to search for products and services.
• Full Visibility Report: For a subscription fee of $20 per month, business owners receive monthly detailed reports showing how customers and AI assistants discover their business, along with recommended improvements designed to strengthen online visibility and potentially increase customer traffic.
• On-Demand Visibility Monitoring: Subscribers can access and refresh their visibility reports as often as desired, enabling them to monitor changes in their AI search presence and competitive positioning over time.
• Optional Implementation Services: Following the full visibility report, subscribers can engage Beacon’s services team to implement recommended improvements on their behalf, providing an additional potential revenue opportunity beyond monthly subscriptions.

The Company believes Beacon’s combination of automated analysis, actionable recommendations, and affordable subscription pricing can help address a gap in the small business market, where sophisticated digital marketing and AI optimization services have historically been difficult or costly for smaller organizations to access.

Targeting the U.S. Small Business Market

Beacon is initially targeting an estimated 5.6 million U.S. small businesses with fewer than 50 employees, representing a substantial potential market for affordable AI-powered visibility and optimization services.

The Company’s go-to-market strategy will emphasize the platform’s free initial visibility audit, allowing business owners to evaluate their AI presence before deciding whether to subscribe to ongoing monitoring and optimization services.

Management believes this approach can support broad product awareness, encourage subscription conversion, and create opportunities for recurring revenue as Beacon’s customer base expands.

“We believe Beacon represents an attractive opportunity to translate the growing adoption of AI into a practical, revenue-generating application for millions of small businesses,” added Mathews. “Our initial focus will be on driving awareness and converting free audits into paid subscriptions. As adoption increases, we believe Beacon has the potential to become an important source of recurring SaaS revenue and further validate our broader agentic AI commercialization strategy.”

Beacon is scheduled to launch commercially on October 28, 2026, at www.thebeaconapp.com.

About Change Agents Corporation

Change Agents Corporation (Nasdaq: CHGA) is a developer of agentic artificial intelligence software solutions. The Company is expanding its strategy into AI-enabled autonomous air defense and counter-UAS technologies through its wholly owned subsidiary, Autonomous Air Defense LLC. Change Agents is evaluating technologies, strategic partnerships and acquisition opportunities intended to position the Company in markets where artificial intelligence, autonomous systems and advanced defense technologies converge. The Company’s current portfolio includes Beacon, an AI Search Optimization platform, and Catch-Up, an autonomous AI-powered content creation platform. Through its scalable Software-as-a-Service (SaaS) business model, Change Agents is focused on delivering innovative AI solutions that create measurable customer value while generating recurring subscription revenue and long-term shareholder returns. The Company is seeking to expand into various high growth sectors that are expected to benefit from artificial intelligence.

Change Agents is also distributing the KetoAir™ breathalyzer device a non-invasive consumer breathalyzer that measures ketosis levels and is sold in North America, which is registered with the U.S. Food and Drug Administration as a Class I medical device.

For more information about Change Agents Corp, please visit www.changeagentscorp.com.

Forward-Looking Statements

Forward-looking statements are made based on our expectations and beliefs concerning future events impacting the Company and therefore involve several risks and uncertainties. You can identify these statements by the fact that they use words such as “will,” “anticipate,” “estimate,” “expect,” “should,” “may,” “intend,” “plan,” “believe,” and other words and terms of similar meaning or references to future dates; however, the absence of these words or similar expressions does not mean that a statement is not forward-looking.

These statements include, but are not limited to, statements regarding the anticipated commercial launch of Beacon on October 28, 2026; the platform’s functionality, performance, capabilities, and anticipated benefits; the Company’s ability to successfully commercialize Beacon and attract small business customers; the size and potential of the U.S. small business market; the anticipated demand for AI-powered business visibility and Generative Engine Optimization solutions; the Company’s ability to convert free visibility audits into paid subscriptions; the potential to generate scalable recurring SaaS revenue and additional revenue from implementation services; the Company’s ability to establish partnerships with Chambers of Commerce and other small business organizations; the effectiveness of its customer acquisition and market penetration strategies; and the Company’s broader agentic AI development and commercialization plans.

Market data cited herein is derived from third-party sources that the Company believes to be reliable but has not independently verified. There can be no assurance that Beacon will launch on the anticipated date, achieve meaningful customer adoption, generate recurring subscription revenue, establish anticipated distribution partnerships, or realize the expected commercial benefits. The Company’s ability to successfully commercialize Beacon is subject to various risks, including technical and operational challenges, competition, customer acquisition and retention, changes in third-party AI platforms and search technologies, and the ability to develop and maintain commercially viable software solutions.

Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors disclosed in our filings with the SEC, accessible through the SEC’s website (www.sec.gov), including our most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K filed or furnished with the SEC. In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors, including, without limitation, general industry and market conditions and growth rates, technological developments, economic conditions, competitive pressures, and governmental and public policy changes.

The forward-looking statements included in this press release represent the Company’s views as of the date of this press release, and these views could change. The Company disclaims any obligation to update forward-looking statements, except as required by applicable law. These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to the date of this press release. The contents of any website referenced in this press release are not incorporated by reference herein.

Contact Information:
Change Agents Corp.
ir@changeagentscorp.com

Investor Relations:
Crescendo Communications, LLC
Tel: (212) 671-1020 Ext. 304
CHGA@crescendo-ir.com

GEORGE TOWN, Cayman Islands, Oct. 21, 2026 (GLOBE NEWSWIRE) — Consolidated Water Co. Ltd. (NASDAQ Global Select Market: CWCO), a leading designer, builder, and operator of advanced water treatment plants, today provided an update on permitting and the anticipated construction schedule for its Kalaeloa seawater reverse osmosis desalination project on Oahu, Hawaii.

Since the company’s previous update, the project received approval of its Preservation Plan and Archaeological Monitoring Plan from the State Historic Preservation Division and approval from the Hawaii Department of Health for a Substantial Modification to an Existing Regulated Public Water System. These approvals were required before the company could advance its applications for other permits and approvals.

Several permits and approvals remain outstanding, including a Memorandum of Agreement from the State Historic Preservation Division. Based on the current permitting timeline, Consolidated Water now expects construction to begin in the first half of 2027, compared with its previous expectation of late 2026. The Honolulu Board of Water Supply has granted schedule extensions to reflect the permitting process delays.

In July 2026, the Honolulu Board of Water Supply issued a limited notice to proceed authorizing approximately $6 million for the procurement of long-lead equipment. The early procurement is intended to reduce potential scheduling pressure once the remaining permits and approvals are obtained.

The Kalaeloa facility is being developed under Consolidated Water’s contract to design, build, operate, and maintain a seawater reverse osmosis desalination plant capable of producing 1.7 million gallons of potable water per day. Following commissioning, the company is contracted to operate and maintain the facility for 20 years, with two additional five-year extension options at the client’s discretion.

“We continue to make meaningful progress on the Kalaeloa desalination project,” said Consolidated Water CEO Rick McTaggart. “The recent approvals from the State Historic Preservation Division and the Hawaii Department of Health represent important steps in the permitting process and allow us to advance applications for the remaining permits and approvals. While the permitting timeline has shifted our anticipated construction start to the first half of 2027, the Honolulu Board of Water Supply continues to be supportive and has granted schedule extensions to reflect the process. The limited notice to proceed issued in July is also enabling us to procure long-lead equipment now, which should help the project advance efficiently once the remaining permits and approvals are in place.”

About Consolidated Water Co. Ltd.
Consolidated Water Co. Ltd. develops and operates advanced water treatment plants and water distribution systems. The company designs, constructs, and operates seawater desalination facilities in the Cayman Islands, The Bahamas, and the British Virgin Islands, and designs, constructs, and operates water treatment and reuse facilities in the United States.

The company also manufactures and services a wide range of products and provides design, engineering, management, operating, and other services applicable to commercial and municipal water production, supply and treatment, and industrial water and wastewater treatment.

For more information, visit cwco.com.

Cautionary Note Regarding Forward-Looking Statements

This press release includes statements that may constitute “forward-looking” statements, usually containing the words “believe,” “estimate,” “project,” “intend,” “expect,” “should,” “will” or similar expressions. This press release contains, or may be deemed to contain, “forward-looking statements” (as defined in the U.S. Private Securities Litigation Reform Act of 1995), including statements regarding the anticipated construction schedule and completion of the Kalaeloa desalination facility; the effect of permitting delays on that schedule; the timing and receipt of the remaining permits and approvals; the company’s and the Honolulu Board of Water Supply’s efforts to mitigate those delays; and the company’s ability to perform its design, build, operate, and maintain obligations with respect to the Kalaeloa facility, including the anticipated 20-year operating term and any exercise of the related extension options. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, (i) continued acceptance of the company’s products and services in the marketplace; (ii) changes in its relationships with the governments and clients of the jurisdictions in which it operates, including the Honolulu Board of Water Supply; (iii) the timing and outcome of permitting and other regulatory approvals affecting the Kalaeloa facility; (iv) the company’s ability to procure equipment and perform its contractual obligations on the anticipated timeline and budget, including with respect to the Kalaeloa facility and the Florida purchase orders; (v) changes in demand, consumption levels, operating costs, energy costs, weather, and economic conditions in the jurisdictions in which the company operates; and (vi) various other risks such as economic, operational, and industry-specific risks, as detailed in the company’s periodic report filings with the Securities and Exchange Commission (“SEC”). For more information about risks and uncertainties associated with the company’s business, please refer to the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Risk Factors” sections of the company’s SEC filings, including, but not limited to, its annual report on Form 10-K and quarterly reports on Form 10-Q, copies of which may be obtained by contacting the company’s Secretary at the company’s executive offices or at the “Investors – SEC Filings” page of the company’s website at ir.cwco.com/docs. Except as otherwise required by law, the company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

Company Contact:
David W. Sasnett
Executive Vice President and CFO
Tel (954) 509-8200
Email Contact

Investor & Media Contact:
Ron Both or Grant Stude
Encore Investor Relations
Tel (949) 432-7450
Email Contact

Milestone moves Firefly’s Elytra spacecraft toward final design and hardware production to deliver NASA JPL drones above the lunar south pole

CEDAR PARK, Texas, Oct. 21, 2026 (GLOBE NEWSWIRE) — Firefly Aerospace (Nasdaq: FLY), a market leading space and defense technology company, today announced it completed the preliminary design review (PDR) for its Elytra spacecraft that will deliver drones built by NASA’s Jet Propulsion Laboratory (JPL) to the Moon’s south pole for the agency’s MoonFall mission.

Firefly’s PDR, including members from NASA and JPL, conducted a thorough review of Elytra’s structural, thermal, propulsion, avionics, trajectory design, guidance and navigation, communications and control systems as well as the spacecraft’s qualification and environmental test plans. The review confirmed Elytra’s design meets the mission requirements, and Firefly will now begin working toward the spacecraft’s final critical design review (CDR) ahead of hardware production and assembly.

“Completing PDR less than four months after contract award is a testament to the speed and rigor Firefly brings to every mission,” said Ray Allensworth, Vice President of Spacecraft at Firefly Aerospace. “As NASA accelerates its Moon Base Program, we’re rapidly scaling spacecraft production to support MoonFall and a growing manifest of lunar surface missions, utilizing proven systems, hardware, and operations from our first successful Blue Ghost mission.”

Targeted to be ready for launch by late 2028, MoonFall is part of the first phase of the Moon Base, a long-term lunar exploration and infrastructure initiative designed to enable sustained human presence and expanded scientific and commercial activity at the lunar south pole.

JPL is building the drones and managing the mission for NASA, which will source the launch vehicle for MoonFall. After launching, Firefly’s Elytra spacecraft will transit from Earth orbit to lunar orbit and deploy the drones above the Moon’s south pole. The MoonFall drones will then use their high-definition optical cameras and instruments to survey the south pole terrain and map safe landing spots and resources to support future human missions.

About Firefly Aerospace
Firefly Aerospace is a space and defense technology company on a mission to reliably and repeatedly launch, land, and operate space systems from Earth to the Moon and beyond. As the partner of choice for responsive space missions, Firefly is the first commercial company to launch a satellite to orbit with approximately 24-hour notice and the first to achieve a successful landing on the Moon. Established in 2017, Firefly’s engineering, manufacturing, and test facilities are co-located in central Texas to enable rapid innovation and vertical integration for the company’s small- to medium-lift launch vehicles, lunar landers, and orbital vehicles. For more information, visit www.fireflyspace.com.

Forward-Looking Statement
This press release contains “forward-looking statements” including, but not limited to, statements regarding timing of the MoonFall mission, Elytra and drone performance specifics and capabilities, statements of Firefly’s Vice President of Spacecraft, and other statements regarding Firefly’s future expectations, beliefs, plans, objectives, financial condition, assumptions, future events, or performance that are not historical facts. In some cases, you can identify forward-looking statements because they contain words such as “allows” “enable,” “may,” “position,” “will,” “expects,” “plans,” “anticipates,” “could,” “would,” “target”, “set,” “intends,” “support,” and “believes.” There may also be negative words or other similar terms or expressions that concern our expectations, strategy, plans, or intentions. Not all forward-looking statements contain such identifying words. The inclusion of forward-looking statements should not be regarded as a representation that such plans, estimates, or expectations will be achieved.

Various risks that could cause actual results to differ from those expressed by the forward-looking statements included in this press release include, but are not limited to: our failure to manage our growth effectively, including the increasing technological complexity of our business, and our ability to achieve and maintain profitability; the potential for delayed or failed launches, and any failure of our launch vehicles and spacecraft to operate as intended; our inability to deliver software on time or of a quality that our customers demand; the hazards and operational risks that our products and service offerings are exposed to, including the wide and unique range of risks due to the unpredictability of space; the inability to realize our backlog; the fluctuation of our operating results; adverse publicity stemming from any incident involving us, our competitors, or our customers; the failure to adequately protect our proprietary intellectual property rights; our inability to comply with our contractual obligations; and other risk factors set forth in our filings with the Securities and Exchange Commission.

Readers are cautioned not to place undue reliance on the forward-looking statements contained herein, which speak only as of the date hereof. These statements are based on management’s current expectations, assumptions, and beliefs concerning future developments, which are inherently subject to uncertainties, risks, and changes in circumstances that are difficult to predict. We cannot assure you that the events reflected in the forward-looking statements will occur; actual events could differ materially from those described in the forward-looking statements. We undertake no intent or obligation to publicly update or revise any of the estimates and other forward-looking statements made in this announcement, whether as a result of new information, future events or otherwise, except as required by law.

Media Contact
press@fireflyspace.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/566d99b1-e944-4d41-9c79-df910efa5210

MALVERN, Pa., Oct. 21, 2026 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that it plans to release third quarter 2026 financial and operating results prior to market open on Wednesday, November 4, 2026. The Company will host a conference call to review its results at 8:30 a.m. Eastern Time the same day.

The conference call will be broadcast live in listen-only mode via webcast at Neuronetics Q3 2026 Earnings. To listen to the conference call on your telephone, participants may register for the call here. While it is not required, it is recommended you join 10 minutes prior to the event start.

About Neuronetics

Neuronetics, Inc. is a leader in interventional mental health, combining innovative treatment technologies with direct patient care. Through its NeuroStar® Advanced Therapy system, the company is a leading provider of transcranial magnetic stimulation (TMS) treatment and, through Greenbrook, operates one of the largest interventional psychiatry clinic networks in the United States, offering both TMS and SPRAVATO® therapies. NeuroStar Advanced Therapy is a non-drug, noninvasive treatment that can improve the quality of life for people suffering from neurohealth conditions when traditional medication has not helped. NeuroStar Advanced Therapy is the leading TMS treatment for MDD in adults and is backed by what we believe is the largest clinical data set of any TMS treatment system for depression. Greenbrook treatment centers also offer SPRAVATO® (esketamine) Nasal Spray, a prescription medicine indicated for the treatment of treatment-resistant depression (“TRD”) in adults as monotherapy or in conjunction with an oral antidepressant. It is also indicated for depressive symptoms in adults with MDD with acute suicidal ideation or behavior in conjunction with an oral antidepressant.¹

The NeuroStar Advanced Therapy System is cleared by the U.S. Food and Drug Administration for adults with MDD, as an adjunct for adults with obsessive-compulsive disorder, to decrease anxiety symptoms in adult patients with MDD that may exhibit comorbid anxiety symptoms (anxious depression), and as a first line adjunct for the treatment of MDD in adolescent patients aged 15-21. For safety information and indications for use, visit NeuroStar.com.

Investor Contact:
Mark Klausner
ICR Healthcare
443-213-0499
ir@neuronetics.com

Media Contact:
EvolveMKD
646-517-4220
NeuroStar@evolvemkd.com

References

1 The effectiveness of SPRAVATO® in preventing suicide or in reducing suicidal ideation or behavior has not been demonstrated. Use of SPRAVATO® does not preclude the need for hospitalization if clinically warranted, even if patients experience improvement after an initial dose of SPRAVATO®. For more important safety information about SPRAVATO®, please visit spravatohcp.com.

Phase 1 results demonstrate TMB-365 antiviral activity and tolerability, supporting continued development as a differentiated antibody for combination HIV treatment

Complementary laboratory susceptibility findings support the scientific rationale for the TMB-365/TMB-380 antibody-only maintenance regimen

TAIPEI, Taiwan, Oct. 21, 2026 (GLOBE NEWSWIRE) — TaiMed Biologics (TPEX: 4147), a commercial-stage CD4-targeted biologics company advancing antibody-based therapies for long-acting HIV treatment, today announced results from two studies to be presented at IDWeek 2026, October 21-24 in Washington, D.C. The findings highlight TMB-365’s own clinical activity and potential as a component of multiple long-acting HIV combinations, alongside laboratory evidence of complementary antiviral susceptibility supporting the company’s TMB-365/TMB-380 maintenance regimen.

“These data reinforce our view of TMB-365 as a differentiated antibody with potential across multiple long-acting HIV combinations,” said Jimmy Chang, Ph.D., Chief Executive Officer of TaiMed Biologics. “Its host-directed mechanism, antiviral activity and pharmacokinetic profile provide a foundation for exploring combinations with other antibodies and small-molecule antiretrovirals. TMB-365/TMB-380 is our most advanced application of this approach, and the susceptibility findings strengthen the scientific rationale for pairing these two antibodies.”

TMB-365: Clinical activity and a distinct role in future HIV combinations

TMB-365 is an investigational, second-generation monoclonal antibody derived from ibalizumab. It binds domain 2 of the CD4 receptor on host cells and inhibits HIV entry after attachment, providing a mechanism distinct from antibodies that target the virus directly. TMB-365 was engineered to improve the breadth of antiviral coverage and pharmacokinetics relative to ibalizumab. TaiMed is developing TMB-365 as a distinct antibody asset for use in combination HIV regimens.

The randomized, placebo-controlled Phase 1 study (NCT04027387) evaluated single intravenous doses of 400, 800 and 1,600 mg in 25 people living with HIV over 10 weeks. The lower-dose cohorts included participants with detectable HIV who were off antiretroviral therapy; the 1,600-mg cohort remained on stable combination antiretroviral therapy with suppressed HIV. Key findings included:

• Antiviral activity: Mean maximum HIV-1 RNA reductions were 1.55 and 1.57 log10 copies/mL at 400 and 800 mg, respectively. Antiviral effects were observed for up to two and four weeks, respectively.
• Tolerability: No serious treatment-emergent adverse events, Grade 3 or higher events, or adverse-event-related discontinuations were observed. All 23 treatment-emergent events were mild or moderate; six events in three participants were considered related to TMB-365. No anti-drug antibodies were observed.
• Target engagement and dosing potential: In a limited subset, mean CD4 receptor occupancy remained at or above 80% for five to six weeks at 800 and 1,600 mg. The pharmacokinetic findings support further evaluation of higher doses and dosing intervals of eight to 12 weeks.
• Resistance observations: No resistance or cross-resistance to TMB-365 or approved entry inhibitors was observed during the study.

Together, these results support continued development of TMB-365 beyond a single antibody pairing. Its host-directed mechanism and engineered properties provide a rationale for exploring combinations with complementary antibodies and long-acting small-molecule antiretrovirals. The safety, efficacy and dosing of such future combinations will require clinical evaluation.

TMB-365/TMB-380: Complementary susceptibility supports combination development

The second presentation reports laboratory susceptibility findings for TMB-365 and TMB-380, a broadly neutralizing antibody that targets the CD4-binding site on the HIV envelope protein gp120. Researchers evaluated a panel of 40 HIV pseudotypes: 20 susceptible to TMB-380 and 20 with reduced susceptibility or resistance to TMB-380. They also studied a laboratory-selected virus resistant to LM52, a precursor of TMB-365.

• TMB-365 retained activity against variants less susceptible to TMB-380: Its geometric mean IC50 was similar in the TMB-380-susceptible and reduced-susceptibility groups: 0.054 and 0.057 micrograms/mL, respectively. Of the 20 variants with reduced susceptibility or resistance to TMB-380, 19 were susceptible to TMB-365; one showed incomplete neutralization, with a maximum inhibition of 70%.
• Complementary activity was also seen in the precursor experiment: The LM52-resistant virus became more susceptible to VRC-07 and VRC-01, antibodies related to TMB-380, supporting the hypothesis that the two mechanisms may cover different viral susceptibility gaps.

These in vitro findings support a complementary-activity hypothesis for TMB-365/TMB-380. Their clinical implications for durable viral suppression and resistance outcomes require further study.

“The Phase 1 findings demonstrate TMB-365’s antiviral activity in people living with HIV, while the laboratory study helps explain why its host-directed mechanism could complement a virus-directed antibody,” said Martin Markowitz, M.D., Medical Director of TaiMed Biologics and presenting author of both studies. “TMB-365’s activity against variants with reduced susceptibility to TMB-380 is encouraging. Further clinical studies will determine whether that complementarity translates into durable viral suppression and favorable resistance outcomes.”

TMB-365/TMB-380 is being evaluated as an antibody-only maintenance regimen for virologically suppressed people living with HIV. In the earlier 20-participant Phase 2a study, dosing every eight weeks over 24 weeks produced no protocol-defined virologic failures among participants who completed treatment. An ongoing Phase 2b study is evaluating the regimen against continued oral antiretroviral therapy, with interim results expected by year-end 2026.

IDWeek 2026 presentation details

Oral Presentation 
Title: Single-dose escalation study of TMB-365 in people living with HIV: safety, pharmacokinetics, and antiviral activity.
Date & Time: Friday, October 23, 2:45-2:57 p.m. ET
Session: Hot Off the Press: New Pathways in HIV Treatment
Location: Room 103 AB

Poster Presentation
Title: TMB-365 and TMB-380: A potentially resistance repellant stand-alone maintenance bNAb regimen in suppressed people living with HIV-1 on combination antiretroviral therapy.
Date & Time: Thursday, October 22, 12:15-1:30 p.m. ET
Session: Resistance Mechanisms
Location & Poster Code: Poster Hall B-C, Poster P-82

About TaiMed Biologics
Founded in 2007, TaiMed Biologics (TPEX: 4147) is a leading commercial-stage biotechnology company focused on developing innovative therapies for HIV treatment. The company developed ibalizumab (Trogarzo^®), the first monoclonal antibody approved by the U.S. FDA for the treatment of HIV-1, and is advancing TMB-365/380, its lead clinical-stage long-acting maintenance therapy candidate for people living with HIV. TaiMed Biologics also offers comprehensive contract development and manufacturing (CDMO) services. Its shares trade on the Taipei Exchange.

Forward-Looking Statements
This press release contains forward-looking statements, including statements about the presentation of data at IDWeek 2026 and the development and potential of TMB-365, TMB-380, and the TMB-365/TMB-380 regimen. These statements are based on current expectations and involve risks and uncertainties, including those related to clinical development, regulatory review, and commercialization, that could cause actual results to differ materially. Forward-looking statements speak only as of the date of this release, and TaiMed Biologics undertakes no obligation to update them except as required by law.

Contacts

Investor Relations
Kenny Lin
hlin@taimedbio.com

Media
Mike Tattory
LifeSci Communications
mtattory@lifescicomms.com

LONDON, Oct. 21, 2026 (GLOBE NEWSWIRE) — Apollo, a Skyward Group company (Nasdaq: SKWD), an innovation-inspired insurance platform, today announced it has partnered with Generali to launch a new platform partner syndicate for which it will act as managing agent. Red Bridge Syndicate 2031 has received “in-principle” approval from Lloyd’s and is expected to begin underwriting on 1 January 2027.

Red Bridge will provide an opportunity for Lloyd’s members to share in Generali’s highly diversified outward reinsurance programme that covers multiple lines of business across Europe. For Generali, the syndicate secures access to new sources of capital to support its growth aspirations.

Apollo adds Red Bridge to its growing portfolio of platform partner syndicates at Lloyd’s, further demonstrating the value of Apollo’s differentiated third party syndicate management offering. Through this model, partners benefit from Apollo’s expertise and proven track record of building innovative and profitable underwriting businesses. In addition to traditional managing agency services, Apollo’s Platform Partners benefit from Apollo’s underwriting expertise, bespoke captive syndicate solutions, and access to potential reinsurance and capital opportunities, creating a more comprehensive and differentiated partnership.

Andrew Gray, Director of Partner Syndicates at Apollo, said: “We are delighted to be partnering with Generali in the launch of the Red Bridge syndicate, which brings together two incredible insurance institutions to create an innovative risk transfer solution. We are very proud to have been entrusted with this wonderful opportunity to use our unique expertise to help Generali build a successful and sustainable syndicate for the long term.”

Matthew Newman, PPS development director, at Apollo, said: “Our strategy is to partner with strong businesses and help them build something that lasts at Lloyd’s. Generali is exactly that kind of partner. Apollo has demonstrated existing capabilities to service and operate similar risk transfer opportunities to a diversified capital and investor base, so we know what it takes, and we’re proud Generali has chosen us to build Red Bridge with them.”

Red Bridge will begin underwriting in January 2027. This new partnership brings Apollo’s total number of syndicates under management to 11, further expanding its Platform Partner business and generating additional fee-based revenue for Skyward Group.

About Apollo

Apollo, a Skyward Group company, is an innovation inspired insurance platform operating at Lloyd’s of London, offering data-driven and creative solutions to a wide variety of risks.

The business provides high-quality products and services to clients, and capital partners, enabling a resilient and sustainable world.

Apollo offers products across Property, Casualty, Marine, Energy & Transportation, Specialty, Reinsurance, as well as Smart Follow and digital & embedded risk programs.

Apollo’s experience and unique ecosystem give Platform Partners the best chance of success through the Lloyd’s new entrant process to the delivery of their long-term strategy. For more information about Apollo, please visit apollounderwriting.com.

About Skyward Group

Skyward Group is the holding company brand for its U.S. and U.K. businesses, Skyward Specialty Insurance Group, Inc.® and Apollo, respectively, delivering a comprehensive suite of specialized insurance solutions across global specialty property and casualty markets. Focused on the specialty industry’s most niche, complex risks of today and the emerging challenges of tomorrow, Skyward Group leverages the forward-looking insight and disciplined execution of each organization to drive sustainable growth and long-term value for its shareholders, distribution partners and other stakeholders. For more information about Skyward Group, Skyward Specialty and Apollo, please visit skywardgroup.com.

About the Generali Group

Generali is one of the largest integrated insurance and asset management groups worldwide, with a total premium income of € 98.1 billion and € 900 billion AUM in 2025. Established in 1831, with over 88,000 employees and 163,000 advisors serving 75 million customers, the Group has a leading position in Europe and a growing presence in Asia and America. At the heart of Generali’s strategy is its Lifetime Partner commitment to customers, achieved through innovative and personalised solutions, best-in-class customer experience and its digitalised global distribution capabilities. The Group has fully embedded sustainability into all strategic choices, with the aim to create value for all stakeholders while building a fairer and more resilient society.

MEDIA ENQUIRIES

Haggie Partners

Peter Rigby, Caroline Klein, Ben Rothschild, Finlay Gardner, Ellie Livingstone
Email: Apollo@haggiepartners.com
Tel: + 44 20 7562 4444

Skyward Group

Haley Doughty
Skyward Specialty Insurance Group
hdoughty@skywardinsurance.com
713-935-4944

Investor Contact

Jordan Arnold, Vice President, Investor Relations
Skyward Group 
JArnold@skywardinsurance.com
346.215.0250

Company building on new revenue-generating relationships with potential to substantially expand its business

SHOREHAM, N.Y., Oct. 21, 2026 (GLOBE NEWSWIRE) — Mobiquity Technologies, Inc. (OTCQB: MOBQ) (“Mobiquity” or the “Company”), an AI-powered advertising technology and customer acquisition company, today highlighted several emerging business opportunities that management believes could significantly expand the Company’s revenue base and accelerate long-term growth.

The digital advertising industry is undergoing a fundamental transformation as artificial intelligence reshapes how businesses identify, engage and acquire customers. Mobiquity has already transitioned beyond traditional programmatic advertising through its GrowthOS™ platform, integrating AI-powered customer acquisition, audience intelligence and marketing automation to compete in this evolving marketplace.

“We believe Mobiquity is entering a potentially pivotal stage in its development,” said Dean Julia, Chief Executive Officer. “We are generating revenue from several new commercial relationships and are actively pursuing opportunities to expand them substantially. What makes these opportunities particularly compelling is that several involve established businesses with existing customers, revenue streams and infrastructure, creating the potential to scale more rapidly.”

The Company’s expanding initiatives span digital advertising, music and entertainment, agency services, e-commerce and AI-driven customer acquisition. Management is exploring strategic combinations, deeper commercial relationships and additional revenue channels that could leverage GrowthOS across established customer bases.

Management believes these opportunities, individually and collectively, have the potential to materially transform Mobiquity’s revenue profile and market position.

“Unlike opportunities that require building a business from the ground up, we are working with established commercial relationships that are already producing revenue,” Julia continued. “By combining these relationships with GrowthOS, we see a path toward significantly greater scale, recurring revenue and operating efficiencies.”

Certain opportunities remain subject to further agreements, execution milestones and, where applicable, additional financing, and their ultimate outcomes cannot be guaranteed.

“Our focus is on converting the momentum we are seeing today into sustainable, meaningful growth,” Julia concluded. “We believe the foundation is in place, the opportunities are substantial, and the next phase of Mobiquity’s development could be its most significant yet.”

About Mobiquity Technologies, Inc.

Mobiquity Technologies, Inc. (OTCQB: MOBQ) is a technology company focused on helping organizations identify, engage, convert, and retain customers through intelligent automation. Through its GrowthOS platform, the Company combines customer intelligence, AI-driven decisioning, predictive analytics, and omnichannel execution to help businesses improve customer acquisition outcomes and operational efficiency.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of applicable federal securities laws, including the Private Securities Litigation Reform Act of 1995, to the extent applicable. Such statements include expectations regarding Mobiquity’s GrowthOS platform, AI initiatives, strategic relationships, potential acquisitions, revenue opportunities, financing and future growth. These statements are subject to significant risks and uncertainties, including the Company’s limited financial resources, operating losses, liquidity constraints, ability to obtain additional financing, potential shareholder dilution, customer adoption, technology commercialization and ability to achieve sustainable profitability. Certain opportunities remain preliminary, are not subject to definitive agreements and may require substantial additional capital. Existing revenue-generating relationships do not guarantee future revenue growth, and there can be no assurance that anticipated transactions will close, financing will be available on acceptable terms, or projected business opportunities will materialize. Failure to secure sufficient capital could require the Company to significantly curtail operations, restructure or discontinue portions of its business, or cease operations entirely. Actual results may differ materially from management’s expectations. Additional risks are described in the Company’s filings with the Securities and Exchange Commission at www.sec.gov. Forward-looking statements speak only as of the date made, and the Company undertakes no obligation to update them except as required by law.

MEDIA CONTACTS

Mobiquity Technologies
Deep Katyal
info@mobiquitytechnologies.com
516-246-9422

After a custodianship that cleared legacy liabilities and restored the Company to good standing, GBHL plans to combine with PYX Wallets, a developer of titanium smart wallets that combine physical card security, fingerprint access, connected app controls and offline crypto protection

LAS VEGAS, Oct. 21, 2026 (GLOBE NEWSWIRE) — Global Entertainment Holdings, Inc. (OTC: GBHL) (“GBHL” or the “Company”) today announced that on October 16, 2026, it signed a binding letter of intent (the “Agreement”) with PYX Wallets Inc. (“PYX”). Under the Agreement, PYX would acquire voting control of GBHL and contribute its business to the Company. The parties expect to sign definitive agreements and complete the change of control on or before October 30, 2026.

About the PYX Platform

Wallets protect what people carry every day, but they have changed little in decades. PYX is developing titanium smart wallets that combine physical card protection with fingerprint access and connected controls through mobile and desktop apps. PyX Core is designed to protect everyday cards, with GPS tracking and RFID/NFC shielding. PyX Vault combines Core’s connected security features with a hardware crypto wallet, bringing physical cards and crypto cold storage together in one device. Planned features include the ability to:

• Unlock the wallet using the biometric fingerprint sensor located on the side or through the PYX app, and manage multiple saved fingerprints through the app.
• Locate the wallet with built-in GPS, activate Lost Mode through the PYX app if the wallet is lost or goes missing, and check battery level in the app. Built-in RFID/NFC shielding helps protect cards from unauthorized scans.
• Store crypto private keys offline with PyX Vault and review the amount and recipient on its integrated display before approving transactions on the wallet. Planned Vault app features include buying, sending and receiving crypto.

PyX Core and PyX Vault are currently in development, and their final design, features and functionality may change before launch. For more information, visit www.pyxwallets.com.

What Comes Next

When the change of control closes, PYX would become the control person of GBHL and appoint the Company’s officers and directors.

The parties have agreed to use their best efforts to complete audited financial statements for the combined company and file a registration statement with the SEC within 90 days after the change of control. Once the registration statement is effective, the Company may raise additional capital to support the launch of PYX’s products.

“People carry their cards every day, while more of their financial lives are becoming digital. We believe their wallet should evolve with them,” said Ryan Contardi, Chief Executive Officer of PYX Wallets. “We are building PYX around that idea, combining a premium look and feel with technology that puts control of the wallet in its owner’s hands. Whether people want smarter protection for everyday cards or the option to bring physical cards and digital assets together, PYX is designed to make their wallet work on their terms.”

“When the court appointed a custodian, GBHL had been abandoned by its former management and had no operations,” said Richard C. Hawkins, Chief Executive Officer of GBHL. “We rebuilt it with the support from the court through the custodianship process and with full disclosure so shareholders would have a clean company to build on. PYX brings a new business and product line to that foundation. Now the work is to hit each milestone, starting with the audit and filing with the SEC.”

Court Custodianship

The Agreement is the first strategic transaction for GBHL since its restoration. The Company’s former management abandoned it in 2023, leaving it with no operations.

In May 2025, the Eighth Judicial District Court of Nevada appointed a custodian. The custodian reinstated the Company with the Nevada Secretary of State, appointed interim officers and directors, and ran a court-supervised creditor-notice process. In March 2026, the Court entered an order barring unasserted claims. On September 28, 2026, stockholders ratified the custodian’s actions, elected new management and approved the cancellation of 3,702,000,000 shares issued under a rescinded 2023 share exchange. The custodian has since filed a motion asking the Court to discharge the custodianship and enter a final order, which is pending.

The cleanup is reflected on the balance sheet. Total reported liabilities fell from approximately $856,000 at December 31, 2025 to approximately $384,000 at September 30, 2026, after the Company recognized a gain of approximately $494,000 on liabilities barred by the court order.

About PYX Wallets

PYX Wallets Inc. is a Delaware corporation developing titanium smart wallets that combine fingerprint access, physical card protection and connected app controls. PyX Core is designed for everyday card security. PyX Vault combines Core’s connected security features with a hardware crypto wallet, keeping private keys offline and providing on-device transaction review and approval. For more information, visit www.pyxwallets.com.

About Global Entertainment Holdings, Inc.

Global Entertainment Holdings, Inc. is a Nevada corporation quoted on OTC Markets under the symbol “GBHL.” Following a court-supervised custodianship, the Company is pursuing a strategic transaction to establish new operations.

Investor Contact
info@gbhlinc.com | +1 480-788-7420

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements, including statements regarding the proposed change of control under the letter of intent, the execution of definitive agreements, the transfer of voting and board control, PYX vending its business into the Company, the discharge of the custodianship, financing plans, reporting status, the completion of audited financial statements and the filing of a registration statement, and the development, features and launch of PYX’s products. Forward-looking statements can be identified by words such as “would,” “intends,” “contemplates,” “anticipates,” “plans,” “expects” and similar expressions.

These statements are based on current expectations and are subject to significant risks and uncertainties, including: that the letter of intent may be terminated under its terms, including if definitive agreements are not executed within 30 days, with certain obligations surviving; that definitive agreements may not be executed or the change of control may not be completed; that the Court may not enter a final order discharging the custodianship when expected or at all; that the required audit and registration statement may not be completed within the contemplated time frame or at all; that PYX’s products are in development and may not be completed, manufactured or launched on the expected timeline, at the expected cost or at all, and that their final design and features may change; that PYX’s products may not achieve market acceptance; that PYX may face competition from established wallet and hardware crypto-wallet makers; that the digital-asset features of PYX’s products may be affected by evolving laws and regulations; that additional funding may not be available on acceptable terms or at all; that securities remain subject to applicable former-shell-company resale restrictions under Rule 144(i); and that existing indebtedness and future financing may substantially dilute common stockholders. The super-voting preferred stock would concentrate voting control in PYX even if PYX’s common equity ownership is diluted.

The safe harbor for forward-looking statements provided by Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 is not available to the Company. The Company undertakes no obligation to update any forward-looking statement except as required by law.

This press release is for informational purposes only. It does not constitute an offer to sell or the solicitation of an offer to buy any security, and there shall be no sale of any security in any jurisdiction in which such offer, solicitation or sale would be unlawful. Any offering of securities will be made only in accordance with applicable law and, where applicable, pursuant to an effective registration statement or qualified offering statement and the delivery of a prospectus or offering circular.

Source: Global Entertainment Holdings, Inc.

CULVER CITY, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) — Snail, Inc. (Nasdaq: SNAL) (“Snail Games” or the “Company”), a leading global independent developer and publisher of interactive digital entertainment, today highlighted continued progress across its gaming portfolio, with an upcoming launch for Dead Party, positive early reception for The Fame Game II, three indie titles featured in Steam Next Fest, and expanded visibility for internally developed titles following IGN Fan Fest. Together, these milestones demonstrate continued activity across the Company’s publishing and development pipeline as it works to introduce new experiences to players and advance titles toward launch.

Dead Party sets October 29, 2026 launch date
Developed by Radiation Blue in collaboration with Snail Games USA, Dead Party is scheduled to launch on Steam on October 29, 2026. The four-player cooperative zombie survival game challenges players to work together to defend their neighborhood against waves of the undead. Its expanded Steam Next Fest demo lets players experience the cooperative gameplay ahead of launch, connecting the game’s current promotional activity with its upcoming commercial release.

The Fame Game II: LA Heartbreaker earns “Overwhelmingly Positive” Steam rating
Launched on Steam last week, The Fame Game II: LA Heartbreaker received a “Very Positive” rating at launch and an “Overwhelmingly Positive” rating to date, with more than 500 reviews. The early reception marks an encouraging milestone for the title and adds to the range of activities across the Interactive Films portfolio.

Expanding player engagement and visibility through Steam Next Fest and IGN Fan Fest
Snail Games is participating in this week’s Steam Next Fest with new demos for Dead Party, Whispers of West Grove, and Veil of Madness. The showcase allows players to experience the titles firsthand while increasing their visibility on Steam. By bringing multiple titles to the festival, Snail Games continues to build awareness across its portfolio and create opportunities for players to discover upcoming releases.

Last week, Snail Games participated in IGN Fan Fest, providing additional insight into For the Stars, its open-world science-fiction survival title, and 9 Yin Sutra: Immortal, a fantasy open-world experience. The showcase offered another opportunity to introduce these projects to gaming audiences and highlight the breadth of the Company’s development pipeline beyond its current publishing releases.

Learn more about the presence of 9 Yin Sutra: Immortal and For The Stars at IGN FanFest below:
Watch 9 Yin Sutra: Immortal IGN FanFest Trailer
Read For The Stars IGN FanFest Article + Exclusive New Images

As Snail Games continues to advance through the quarter, the Company remains focused on supporting upcoming releases, strengthening player awareness, and developing original experiences.

About Snail, Inc.
Snail, Inc. (Nasdaq: SNAL) is a leading, global independent developer and publisher of interactive digital entertainment for consumers around the world, with a premier portfolio of premium games designed for use on a variety of platforms, including consoles, PCs, and mobile devices. For more information, please visit: https://snail.com/.

Forward-Looking Statements
This press release contains statements that constitute forward-looking statements. Many of the forward-looking statements contained in this press release can be identified by the use of forward-looking words such as “anticipate,” “believe,” “could,” “expect,” “should,” “plan,” “intend,” “may,” “predict,” “continue,” “estimate” and “potential,” or the negative of these terms or other similar expressions. These forward-looking statements include information about possible or assumed future results of Snail Games’ business, financial condition, results of operations, liquidity, plans and objectives. Forward-looking statements appear in a number of places in this press release and include, but are not limited to, statements regarding the milestones demonstrating continued activity across the company’s publishing and development pipeline as it works to introduce new experiences to players and advance titles toward the market; Snail continuing to build awareness across its portfolio and creating opportunities for players to discover upcoming releases; and Dead Party being scheduled to launch on Steam on October 29, 2026; Further information on risks, uncertainties and other factors that could affect Snail Games’ financial results and business is included in its filings with the Securities and Exchange Commission (the “SEC”) from time to time, including its ability to continue to build awareness across its portfolio and publish and develop a pipeline that is attractive to players and the other risk factors set forth in its most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q filed, or to be filed, with the SEC. You should not rely on these forward-looking statements, as actual outcomes and results may differ materially from those expressed or implied in the forward-looking statements as a result of such risks and uncertainties. All forward-looking statements in this press release are based on management’s beliefs and assumptions and on information currently available to Snail Games, and Snail Games does not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.

Investor Contact:
John Yi and Steven Shinmachi
Gateway Group, Inc.
949-574-3860
SNAL@gateway-grp.com